Skip to main content
. Author manuscript; available in PMC: 2023 Apr 5.
Published in final edited form as: Genet Med. 2022 Feb 23;24(5):1130–1138. doi: 10.1016/j.gim.2022.01.015

Figure 1. Outcome of disclosure of P/LP variants to eMERGE3 participants.

Figure 1

Diagram illustrating the number of enrolled participants in eMERGE3, participants with return of results, and the breakdown of numbers and reasons why participants did not have return of results. eMERGE3, Electronic Medical Records and Genomics Phase III; LP, likely pathogenic; P, pathogenic.